News

• NICE recommends Jyseleca® ▼(filgotinib) on NHS in landmark decision for rheumatoid arthritis
  08:08 - GlobeNewswire
•  
• Jounce Therapeutics Announces Initiation of Phase 1 INNATE Study of JTX-8064 (LILRB2/ILT4 Inhibitor) Monotherapy and PD-1 Inhibitor Combination Therapy in Patients with Advanced Solid Tumors
  01/13/2021 / 14:00 - GlobeNewswire
•  
• Gilead holds 25.54% of Galapagos shares
  01/11/2021 / 22:01 - GlobeNewswire
•  
• Remdesivir could work against new COVID strains - Gilead
  01/11/2021 / 15:21 - TeleTrader
•  
• Intercept Appoints Jared M. Freedberg as General Counsel and Secretary
  01/11/2021 / 14:00 - GlobeNewswire
•  
• Gilead raises 2020 guidance on strong remdesivir sales
  01/11/2021 / 13:21 - TeleTrader
•  
• Jounce Therapeutics to Present at Upcoming Investor Conferences in January
  01/08/2021 / 14:00 - GlobeNewswire
•  
• Vaxcyte Promotes Andrew Guggenhime to President and Chief Financial Officer
  12/22/2020 / 14:00 - GlobeNewswire
•  
• In Addition to Addressing COVID Vaccine Shipping and Storage Requirements, Reflect Scientific’s Proprietary Liquid Nitrogen-based Freezers are Continuing to Support Growing Cell and Gene Therapy Market Requirements for Ultra-Low Temperature Processing and Storage
  12/21/2020 / 14:00 - GlobeNewswire
•  
• Jounce Therapeutics Added to NASDAQ Biotechnology Index
  12/16/2020 / 14:00 - GlobeNewswire
•  
• Gilead  and  Galapagos  announce  New  Commercialization  and  Development  Agreement  for  Jyseleca®  (filgotinib)  
  12/15/2020 / 22:15 - GlobeNewswire
•  
• RENOWN INSTITUTE FOR HEALTH INNOVATION EXPANDS PARTNERSHIP WITH GILEAD SCIENCES AND SIEMENS HEALTHINEERS TO OFFER ELF- ENHANCED LIVER FIBROSIS TESTING FOR NEVADA NASH STUDY PARTICIPANTS
  12/15/2020 / 16:23 - GlobeNewswire
•  
• Potter Anderson Announces New Partner and Counsel
  12/15/2020 / 15:05 - GlobeNewswire
•  
• Cidara Therapeutics Appoints Biotechnology Industry Veteran Christopher Kurtz As Executive Vice President of Technical Operations
  12/15/2020 / 14:00 - GlobeNewswire
•  
• Sarepta Therapeutics Announces Executive Management Changes
  12/14/2020 / 14:30 - GlobeNewswire